Systematic review of human and animal studies examining the efficacy and safety of N-acetylcysteine (Nac) and N-acetylcysteine amide (Naca) in traumatic brain injury : impact on neurofunctional outcome... : D68-10/084-2018E-PDF
"No new therapies for traumatic brain injury (TBI) have been officially translated into current practice. At the tissue and cellular level, both inflammatory and oxidative processes may be exacerbated post-injury and contribute to further brain damage. N-acetylcysteine (NAC) has the potential to downregulate both processes. This review focuses on the potential neuroprotective utility of NAC and N-acetylcysteine amide (NACA) post-TBI"--Background, page 1.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.880700&sl=1
| Ministère/Organisme | Canada. Defence R&D Canada. Defence R&D Canada. Toronto Research Centre. |
|---|---|
| Titre | Systematic review of human and animal studies examining the efficacy and safety of N-acetylcysteine (Nac) and N-acetylcysteine amide (Naca) in traumatic brain injury : impact on neurofunctional outcome and biomarkers of oxidative stress and inflammation / Junaid Bhatti [and six others]. |
| Titre de la série | External literature (P) ; DRDC-RDDC-2018-P084 |
| Type de publication | Série - Voir l'enregistrement principal |
| Langue | [Anglais] |
| Format | Électronique |
| Document électronique | |
| Note(s) | "Can unclassified." "June 2018." "Journal of Frontiers in Neurology, doi: 10.3389/fneur.2017.00744, Volume 8, Article 744." "Date of publication from Ext publisher: January 2018." Includes bibliographical references (pages 12-14). |
| Information sur la publication | Toronto, Ontario : DRDC - Toronto Research Centre, Defence Research and Development Canada, 2018. ©2018 |
| Auteur / Contributeur | Bhatti, Junaid, author. |
| Description | 1 online resource (14 pages, 2 unnumbered pages) |
| Numéro de catalogue |
|
| Descripteurs | Injuries Medical research |